Shared Gene Expression Alterations in Schizophrenia and Bipolar Disorder

Biological Psychiatry

Volumn 64, Issue 2, 2008, Pages 89-97

  Shao, Ling ^a   Vawter, Marquis P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AGXT2L1; antipsychotic medication; apoptosis; bipolar disorder; BUB1B; dorsolateral prefrontal cortex; EMX2; ERBB2; FGF2; FTH1; IL2RA; LGALS3; MAFG; microarray; neurogenesis; NFATC1; PVR; quantitative PCR; RERG; schizophrenia; SLC1A2; SMCY; SMO; SOX9; TU3A; TXNIP

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 2; RNA;

ADULT; AGE DISTRIBUTION; ANALYSIS OF COVARIANCE; ARTICLE; BIPOLAR DISORDER; CELL DEATH; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FISHER EXACT TEST; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RNA ISOLATION; SCHIZOPHRENIA; SEX DIFFERENCE;

ADULT; BIPOLAR DISORDER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SOCIAL ENVIRONMENT; TRANSAMINASES; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 45449091369     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.11.010     Document Type: Article

References (50)

1. Craddock N., O'Donovan M.C., and Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 42 (2005) 193-204
2. Craddock N., and Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186 (2005) 364-366
3. Craddock N., O'Donovan M.C., and Owen M.J. Genes for schizophrenia and bipolar disorder?. Implications for psychiatric nosology. Schizophr Bull 32 (2006) 9-16
4. Craddock N., O'Donovan M.C., and Owen M.J. Symptom dimensions and the Kraepelinian dichotomy. Br J Psychiatry 190 (2007) 361 author reply 361-362
5. Owen MJ, Craddock N, Jablensky A (2007): The Genetic Deconstruction of Psychosis. 33:905-911.
6. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., and Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 9 (2004) 406-416
7. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14 (2005) 241-253
8. Tomita H., Vawter M.P., Walsh D.M., Evans S.J., Choudary P.V., Li J., et al. Effect of agonal and postmortem factors on gene expression profile: Quality control in microarray analyses of postmortem human brain. Biol Psychiatry 55 (2004) 346-352
9. Vawter M.P., Tomita H., Meng F., Bolstad B., Li J., Evans S., et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders. Mol Psychiatry 11 (2006) 663-679
10. Benjamini Y., and Hochberg Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J Royal Stat Soc B Methodol 57 (1995) 289-300
11. Vawter M.P., Evans S., Choudary P., Tomita H., Meador-Woodruff J., Molnar M., et al. Gender-specific gene expression in post-mortem human brain: Localization to sex chromosomes. Neuropsychopharmacology 29 (2004) 373-384
12. Lee H.K., Braynen W., Keshav K., and Pavlidis P. ErmineJ: Tool for functional analysis of gene expression data sets. BMC Bioinformatics 6 (2005) 269
13. Erraji-Benchekroun L., Underwood M.D., Arango V., Galfalvy H., Pavlidis P., Smyrniotopoulos P., et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 57 (2005) 549-558
14. Galfalvy H.C., Erraji-Benchekroun L., Smyrniotopoulos P., Pavlidis P., Ellis S.P., Mann J.J., et al. Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics 4 (2003) 37
15. Altar C.A., Jurata L.W., Charles V., Lemire A., Liu P., Bukhman Y., et al. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 58 (2005) 85-96
16. Li J.Z., Vawter M.P., Walsh D.M., Tomita H., Evans S.J., Choudary P.V., et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13 (2004) 609-616
17. Li JZ, Meng F, Tsavaler L, Evans SJ, Choudary PV, Tomita H, et al. (2007): Sample matching by inferred agonal stress in gene expression analyses of the brain. 8:336.
18. Atz M., Walsh D., Cartagena P., Li J., Evans S., Choudary P., et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Meth 163 (2007) 295-309
19. Mexal S., Berger R., Adams C.E., Ross R.G., Freedman R., and Leonard S. Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res 1106 (2006) 1-11
20. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101 (2004) 6062-6067
21. Dranovsky A., and Hen R. Hippocampal neurogenesis: Regulation by stress and antidepressants. Biol Psychiatry 59 (2006) 1136-1143
22. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
23. Harwood A.J. Neurodevelopment and mood stabilizers. Current molecular medicine 3 (2003) 472-482
24. Jarskog L.F. Apoptosis in schizophrenia: Pathophysiologic and therapeutic considerations. Curr Opin Psychiatry 19 (2006) 307-312
25. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72 (1999) 879-882
26. McQuillin A., Rizig M., and Gurling H.M. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics 17 (2007) 605-617
27. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 102 (2005) 15653-15658
28. McCullumsmith R.E., and Meador-Woodruff J.H. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26 (2005) 368-375
29. Smith R.E., Haroutunian V., Davis K.L., and Meador-Woodruff J.H. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 158 (2001) 1393-1399
30. Balcar V.J., and Nanitsos E.K. Autoradiography of (3H)aspartate and glutamate transport in schizophrenia. Neuropsychopharmacology 31 (2006) 685-686 author reply 687-688
31. Lauriat T.L., Dracheva S., Chin B., Schmeidler J., McInnes L.A., and Haroutunian V. Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 137 (2006) 843-851
32. Berger UV, Hediger MA (2006): Distribution of the glutamate transporters GLT-1 (SLC1A2) and GLAST (SLC1A3) in peripheral organs. 211:595-606.
33. Deng X., Shibata H., Ninomiya H., Tashiro N., Iwata N., Ozaki N., et al. Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia. BMC Psychiatry 4 (2004) 21
34. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (2006) 1116-1127
35. Newton S.S., and Duman R.S. Regulation of neurogenesis and angiogenesis in depression. Curr Neurovasc Res 1 (2004) 261-267
36. Lee Y., Duman R.S., and Marek G.J. The mGlu2/3 receptor agonist LY354740 suppresses immobilization stress-induced increase in rat prefrontal cortical BDNF mRNA expression. Neurosci Lett 398 (2006) 328-332
37. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol Med 5 (2004) 11-25
38. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
39. D'Sa C., and Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord 4 (2002) 183-194
40. Jurata L.W., Bukhman Y.V., Charles V., Capriglione F., Bullard J., Lemire A.L., et al. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Meth 138 (2004) 173-188
41. Thompson M., Lauderdale S., Webster M.J., Chong V.Z., McClintock B., Saunders R., et al. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res 1139 (2007) 95-109
42. Britsch S. The neuregulin-I/ErbB signaling system in development and disease. Advances in anatomy, embryology, and cell biology. Cell Biol 190 (2007) 1-65
43. Law A. Schizophrenia, IV: Neuregulin-1 in the human brain. Am J Psychiatry 160 (2003) 1392
44. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71 (2002) 877-892
45. Harrison P.J., and Owen M.J. Genes for schizophrenia?. Recent findings and their pathophysiological implications. Lancet 361 (2003) 417-419
46. Sun X., Wang J.F., Tseng M., and Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 31 (2006) 189-196
47. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9 (2004) 964-997
48. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., and Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61 (2004) 300-308
49. Weis S., Llenos I.C., Dulay J.R., Elashoff M., Martinez-Murillo F., and Miller C.L. Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Meth 165 (2007) 198-209
50. Arion D., Unger T., Lewis D.A., Levitt P., and Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 62 (2007) 711-721